EUCTR2015-001923-22-NL
Active, not recruiting
Phase 1
The effect of adenosine on myocardial protection in intermittent warm blood cardioplegia: a randomized placebo-controlled trial
Amphia Ziekenhuis0 sites100 target enrollmentNovember 19, 2015
ConditionsPost-operative cardiac damage in patients scheduled for minimal invasive, port-access operationsTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
DrugsAdenocor
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Post-operative cardiac damage in patients scheduled for minimal invasive, port-access operations
- Sponsor
- Amphia Ziekenhuis
- Enrollment
- 100
- Status
- Active, not recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Gender; male/ female
- •Age: \= 18 year
- •Elective cardiac surgical patients: \- minimally invasive, port access surgery (mitral valve surgery)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 50
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range 50
Exclusion Criteria
- •Patients who meet any of the following criteria will be excluded from participation in this study:
- •All non\-minimally invasive surgery
- •Theophylline or dipyridamole use
- •Caffeine use up to 12 hours prior to surgery
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
The effect of Adenosine on Myocardial Protection in Intermittent warm blood Cardioplegia: a randomized placebo-controlled trialNL-OMON42535Amphia Ziekenhuis100
Unknown
Phase 2
Adenosine as an Adjunct to Blood CardioplegiaPathological ProcessesCardiomyopathiesNCT02681913Amphia Hospital100
Completed
Phase 1
Myocardial Protection With Adenosine PreconditioningHeart Defects, CongenitalCardiac Surgical ProceduresMyocardial Reperfusion InjuryAdenosineNCT00881686Xijing Hospital238
Not yet recruiting
Not Applicable
TO STUDY IF THE USE OF ADENOSINE IN CONGENITAL HEART SURGERY HAS A PROTECTIVE EFFECT OVER THE HEART FUNCTIOHealth Condition 1: I52- Other heart disorders in diseasesclassified elsewhereHealth Condition 2: null- Patients of pediatric age group with congenital cardiac defects weighing less than 20 kgsCTRI/2018/08/015385DirectorAIIMS
Unknown
Phase 2
Salvage: Postconditioning With Adenosine for STEMIAcute ST Elevation Myocardial InfarctionNCT00284323University Hospital, Gasthuisberg100